Rosen CJ.The rosiglitazone story-lessons from an FDA Advisory Committee meeting. N Engl J Med 357:844-846

ArticleinNew England Journal of Medicine 357(9):844-6 · September 2007with4 Reads
Impact Factor: 55.87 · DOI: 10.1056/NEJMp078167 · Source: PubMed